Neovascularization
Neovascularization is the natural process in the body where new blood vessels are formed from pre-existing vessels. This process is crucial in the body's normal growth and development, as well as in wound healing and the formation of granulation tissue. However, it is also a fundamental step in the transition of tumors from a benign state to a malignant one, leading to the use of angiogenesis inhibitors in the treatment of cancer.
Mechanism[edit | edit source]
Neovascularization is regulated by chemical signals in the body. These signals may be either pro-angiogenic signals, which stimulate the growth of new vessels, or anti-angiogenic signals, which inhibit the growth. The process of neovascularization is considered to occur in several stages, including vasodilation, endothelial cell migration, proliferation, and tube formation.
Types[edit | edit source]
There are two types of neovascularization: physiological and pathological.
Physiological[edit | edit source]
Physiological neovascularization is a normal process that occurs in the body. It is essential for the body's growth and development, and for wound healing. It is also involved in the menstrual cycle and in the formation of the placenta during pregnancy.
Pathological[edit | edit source]
Pathological neovascularization, on the other hand, is abnormal and can lead to a number of diseases. It is a fundamental step in the transition of tumors from a benign state to a malignant one, and is therefore a target for cancer treatment. It can also occur in the eye, leading to conditions such as diabetic retinopathy and age-related macular degeneration.
Clinical significance[edit | edit source]
Neovascularization plays a crucial role in the growth and spread of cancer. Tumors stimulate the growth of new blood vessels because they need a blood supply to grow. This process is called tumor angiogenesis. Inhibiting angiogenesis is a potential way to prevent the growth and spread of cancer.
Neovascularization is also involved in a number of eye diseases, including diabetic retinopathy and age-related macular degeneration. In these conditions, abnormal blood vessels grow in the retina, which can lead to vision loss.
See also[edit | edit source]
References[edit | edit source]
| Neovascularization Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
